Zai Lab Pre-Tax Profit Margin 2016-2022 | ZLAB
Zai Lab pre-tax profit margin from 2016 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Zai Lab Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2022-03-31 |
$0.17B |
$-0.55B |
-322.81% |
| 2021-12-31 |
$0.14B |
$-0.70B |
-488.19% |
| 2021-09-30 |
$0.12B |
$-0.57B |
-493.91% |
| 2021-06-30 |
$0.09B |
$-0.54B |
-614.94% |
| 2020-12-31 |
$0.04B |
$-0.19B |
-492.11% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.927B |
$0.144B |
|
Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.
|
